Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin

A new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin, according to a phase 2 clinical trial. The study results compared an investigational drug called basal insulin Fc (BIF) with insulin degludec, a commercially available long-lasting daily insulin, in patients with type 2 diabetes.

from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/03/210321215440.htm
Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin Reviewed by cmakigo on March 22, 2021 Rating: 5

No comments:

'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();
Powered by Blogger.